{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0013534/OMIM:614028","label":"Hyperalphalipoproteinemia 2","mondoId":"MONDO:0013534","onsetQualifier":null,"recordKeys":["0af373c84a2441ff30894ff37d102794077dc59f3ea18a557740eac7166e520f","6dd605e7ac27a5684b4856ac6ec48bd19dd793dd424966281c2774a97e6007d6","840a15f0aa60b8ed4672b39c8db0c7481b970059c945f3905d581a9609dd639c"],"recordQualifiers":{},"scopeLabel":"OMIM:614028","sourceIds":["OMIM:614028"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0013534/OMIM:614028"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":3,"sourceGroups":{"omim":0,"orphanet":0,"published":3}},"features":[{"hpoId":"HP:0003563","label":"Decreased circulating LDL-C concentration","primary":false},{"hpoId":"HP:0012184","label":"Elevated circulating HDL-C concentration","primary":false},{"hpoId":"HP:0012153","label":"Hypotriglyceridemia","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0013534","records":[{"frequencyKind":"reported","key":"0af373c84a2441ff30894ff37d102794077dc59f3ea18a557740eac7166e520f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614028","disease_name":"Hyperalphalipoproteinemia 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003563","is_excluded":false,"label":"Decreased circulating LDL-C concentration","onset_id":null,"reference":"PMID:19074352","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"6dd605e7ac27a5684b4856ac6ec48bd19dd793dd424966281c2774a97e6007d6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614028","disease_name":"Hyperalphalipoproteinemia 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0012184","is_excluded":false,"label":"Elevated circulating HDL-C concentration","onset_id":null,"reference":"PMID:19074352","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"840a15f0aa60b8ed4672b39c8db0c7481b970059c945f3905d581a9609dd639c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614028","disease_name":"Hyperalphalipoproteinemia 2","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0012153","is_excluded":false,"label":"Hypotriglyceridemia","onset_id":null,"reference":"PMID:19074352","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"apolipoprotein-c-iii-deficiency","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"apolipoprotein c-III deficiency"},"schemaVersion":1}